EXOCEL BIO Revenue and Competitors
Estimated Revenue & Valuation
- EXOCEL BIO's estimated annual revenue is currently $4M per year.
- EXOCEL BIO's estimated revenue per employee is $155,000
Employee Data
- EXOCEL BIO has 26 Employees.
- EXOCEL BIO grew their employee count by 8% last year.
EXOCEL BIO's People
Name | Title | Email/Phone |
---|---|---|
1 | Sr. Director - Strategy & Operations | Reveal Email/Phone |
2 | Territory Sales Manager | Reveal Email/Phone |
3 | Regional Sales Manager | Reveal Email/Phone |
4 | Executive Chairman | Reveal Email/Phone |
5 | Principal Research Scientist | Reveal Email/Phone |
6 | Senior Account Executive | Reveal Email/Phone |
EXOCEL BIO Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is EXOCEL BIO?
EXOCEL BIO provides a platform of MSC-derived exosomes with the highest potency and safety profile, to drive the next generation of regenerative medicine. (NEXGEN REGENâ„¢). We aim at transforming the Regenerative Medicine space by deploying highly purified and concentrated nanoparticles providing higher safety and effectiveness than currently available therapies.
keywords:N/AN/A
Total Funding
26
Number of Employees
$4M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.5M | 26 | -24% | $145.8M |
#2 | $2.6M | 26 | -19% | N/A |
#3 | $2.7M | 26 | 4% | $5M |
#4 | $2.5M | 26 | N/A | N/A |
#5 | $5.6M | 26 | -10% | N/A |